Cipla Global Highlights

Cipla Global Highlights

-
inhalers
#2

Ranked in sale of inhalers globally

Source: Cipla Annual Report 2022-23

-
Aerosol pMDI
129.10 Million

Aerosol pMDI units produced

-
Nasal spray
43.20 Million

Nasal spray units produced

-
Respule
726.90 Million

Respule units produced

-
Tablets
28.34 Billion

Tablets and capsules produced

read-more-arrow
read-more-arrow